Nexalin Technology (NXL) Non Operating Income (2021 - 2026)
Nexalin Technology's (NXL) quarterly Non Operating Income came in at $23065.0 in Q1 2026, down 3.64% year-on-year from $23936.0 in Q1 2025, and down 37.02% quarter-over-quarter from $36621.0 in Q4 2025.
Nexalin Technology (NXL) Non Operating Income (2021 - 2026) Analysis & Trends
Nexalin Technology's Non Operating Income history runs 6 years deep, the most recent figure standing at $23065.0 for Q1 2026.
- On a quarterly basis, Non Operating Income fell 3.64% year-over-year to $23065.0 in Q1 2026; TTM through Mar 2026 was $168877.0, a 20.82% increase from a year earlier, with the FY2025 full-year figure at $169748.0, up 19.03% from the prior year.
- Non Operating Income eased to $23065.0 in Q1 2026 per NXL's latest filing, from $36621.0 in the prior quarter.
- Across five years, Non Operating Income topped out at $843804.0 in Q4 2023 and bottomed at -$18132.0 in Q1 2022.
- The 5-year median for Non Operating Income is $36621.0 (2025), against an average of $87959.5.
- Across the five-year window, Non Operating Income surged 8487.71% in 2023 and plunged 95.03% in 2024, its largest moves.
- Year by year, Non Operating Income stood at -$10060.0 in 2022, then jumped by 8487.71% to $843804.0 in 2023, then plunged by 95.03% to $41921.0 in 2024, then decreased by 12.64% to $36621.0 in 2025, then plunged by 37.02% to $23065.0 in 2026.
- Per Business Quant, the three latest NXL Non Operating Income figures stand at $23065.0 (Q1 2026), $36621.0 (Q4 2025), and $69320.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 62.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -18.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Nexalin Technology | 9.32 Mn | 6.61 Mn | 13,133.00 | 23,065.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23,065.00 |
| Dec 31, 2025 | 36,621.00 |
| Sep 30, 2025 | 69,320.00 |
| Jun 30, 2025 | 39,871.00 |
| Mar 31, 2025 | 23,936.00 |
| Dec 31, 2024 | 41,921.00 |
| Sep 30, 2024 | 60,101.00 |
| Jun 30, 2024 | 13,819.00 |
| Mar 31, 2024 | 26,772.00 |
| Dec 31, 2023 | 843,804.00 |
| Sep 30, 2023 | 118,348.00 |
| Jun 30, 2023 | 54,423.00 |
| Mar 31, 2023 | 31,012.00 |
| Dec 31, 2022 | -10,060.00 |
| Sep 30, 2022 | 157,793.00 |
| Jun 30, 2022 | -17,302.00 |
| Mar 31, 2022 | -18,132.00 |
| Dec 31, 2021 | -18,439.00 |
| Sep 30, 2021 | -4,259.00 |